LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 96 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2017. The put-call ratio across all filers is 1.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,000 | -58.3% | 1,375 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | -29.4% | 1,375 | -26.7% | 0.00% | – |
| Q2 2019 | $17,000 | -10.5% | 1,875 | -37.5% | 0.00% | – |
| Q1 2019 | $19,000 | +1800.0% | 3,000 | +8471.4% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,872,130 | $77,548,000 | 30.77% |
| RTW INVESTMENTS, LP | 1,084,416 | $29,279,000 | 9.67% |
| Avoro Capital Advisors LLC | 784,199 | $21,173,000 | 7.29% |
| Broadfin Capital, LLC | 1,165,373 | $31,465,000 | 1.94% |
| P.A.W. CAPITAL CORP | 50,400 | $1,361,000 | 1.54% |
| Belmont Global Advisors, Inc. | 37,522 | $1,013,000 | 1.31% |
| Perceptive Advisors | 649,515 | $17,537,000 | 1.30% |
| ACUTA CAPITAL PARTNERS, LLC | 82,920 | $2,239,000 | 1.07% |
| Iguana Healthcare Management, LLC | 110,000 | $2,970,000 | 0.98% |
| Virtus ETF Advisers LLC | 10,250 | $277,000 | 0.76% |